Biotin-Targeted Au(I) Radiosensitizer for Cancer Synergistic Therapy by Intervening with Redox Homeostasis and Inducing Ferroptosis
2022 · Journal of Medicinal Chemistry · 41 citations
https://doi.org/10.1021/acs.jmedchem.2c00300
Y
Yu Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
496
Citations
10
h-index
10
i10-index
Yu Liu is an academic researcher from Nanjing University of Chinese Medicine. The author has contributed to research in topics: Cancer Mechanisms and Therapy & Advanced biosensing and bioanalysis techniques & DNA and Nucleic Acid Chemistry. The author has an h-index of 10, co-authored 24 publications.
ORCID: 0000-0002-8558-7300Papers by this author
worksMicroRNA-375 represses tumor angiogenesis and reverses resistance to sorafenib in hepatocarcinoma
2020 · Cancer Gene Therapy · 36 citations
https://doi.org/10.1038/s41417-020-0191-x
Resveratrol protects against renal ischemia/reperfusion injury: A systematic review and meta-analysis of preclinical studies
2022 · Pharmacological Research - Modern Chinese Medicine · 3 citations
https://doi.org/10.1016/j.prmcm.2022.100040
Effect of probiotic lozenges on improvement in tympanometric classification within 12 weeks in children aged 3–6 years with adenoid hypertrophy and otitis media with effusion undergoing non-surgical management: a randomized controlled trial
2026 · Frontiers in Cellular and Infection Microbiology · 0 citations
https://doi.org/10.3389/fcimb.2025.1736602
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat